INM
Inmed Pharmaceuticals
$1.64
−$0.07 (−4.09%)Jul 27, 2026
Key metrics
The numbers that frame INM today
- Market cap
- $5.44M
- P/E (TTM)
- -0.6
- EV / FCF
- -0.1
- Gross margin
- 35.9%
- EV / Sales
- 0.2
- ROIC
- -668.5%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $0.58
- 52wk High
- $2.71
Growth
Revenue and earnings trend for INM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about INM
Is Inmed Pharmaceuticals a good buy?
No. Inmed Pharmaceuticals has strong momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Inmed Pharmaceuticals is selling at a very high price.
What is the market capitalization of INM?
Inmed Pharmaceuticals's market capitalization is $5.44M.
What is the P/E ratio for INM stock?
Inmed Pharmaceuticals's current P/E ratio is -0.6.
What is the 52-week high for INM stock?
The 52-week high for Inmed Pharmaceuticals is $2.71. The current close of $1.64 is 39.5% below that high.
What is the 52-week low for INM stock?
The 52-week low for Inmed Pharmaceuticals is $0.58. The current close of $1.64 is 185.2% above that low.
Does INM stock pay dividends?
Inmed Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for INM?
Inmed Pharmaceuticals's Debt / Equity ratio is 0.06.